Skip to content

Financial toxicity in patients with gynecological cancer

Financial toxicity in patients with gynecological cancer - FiTGyn

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051616
Enrollment
300
Registered
2023-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C51-C58- Malignant neoplasms of female genital organs

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. All adult women (more than 18 years of age) who got operated for a gynecological cancer at TMC and are willing to give consent to participate in the study 2. Survey will be completed only once by each patient at the completion of treatment (including surgery with or without adjuvant treatment) 3. The participants or their accompanying relative should be well versed with Hindi or English or Marathi

Exclusion criteria

Exclusion criteria: 1. Patients or relatives not willing to participate in the survey 2. Women with recurrent gynecological cancers 3. Women on palliative chemotherapy/radiotherapy/palliative intent of treatment 4. Any known psychiatric condition that may make it difficult to participate

Design outcomes

Primary

MeasureTime frame
To measure financial toxicity (FT) among gynecologic oncology patients and its association with overall quality of life and distress and to evaluate factors affecting it.Timepoint: at baseline

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactPabashi Poddar

Tata Memorial Centre, Mumbai

pabashi@gmail.com9510783797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026